Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Steinke

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.
Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.
Frontiers in Bioengineering and Biotechnology|June 5, 2026
The landscape of antibody production systems: recombinant expression for research, diagnostics and therapyEsther Veronika Wenzel, Laila Al-Halabi-Frenzel, Seyhan Demiral, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Science Advances|May 26, 2023
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathyHa-Yeun Chung, Jonathan Wickel, Nina Hahn, et al.
BMC Medicine|March 3, 2022
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variantMaren Schubert, Federico Bertoglio, Stephan Steinke, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.
Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.
Frontiers in Bioengineering and Biotechnology|June 5, 2026
The landscape of antibody production systems: recombinant expression for research, diagnostics and therapyEsther Veronika Wenzel, Laila Al-Halabi-Frenzel, Seyhan Demiral, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Science Advances|May 26, 2023
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathyHa-Yeun Chung, Jonathan Wickel, Nina Hahn, et al.
BMC Medicine|March 3, 2022
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variantMaren Schubert, Federico Bertoglio, Stephan Steinke, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 2